Charlotte M. Dalsgaard

Novo Nordisk (Denmark)

Papers

1

Total Citations

52

H-Index

1

About

Charlotte M. Dalsgaard is a rising leader in bioinspired drug delivery, with a research focus at the intersection of soft robotics, gastrointestinal medicine, and biomimetic design. Her most celebrated work, the 2024 paper "Cephalopod-inspired jetting devices for gastrointestinal drug delivery," has already garnered 52 citations, reflecting its immediate impact on the field. In this study, Dalsgaard and her team drew inspiration from cephalopod propulsion to create an ingestible robotic device capable of needle-free, high-pressure jet injections directly into the gastrointestinal tract—a breakthrough that could transform the administration of biomacromolecule therapies like insulin and monoclonal antibodies. By eliminating the need for traditional needles, training, and sharps disposal, her innovation addresses critical barriers to patient compliance and global healthcare access. Dalsgaard’s work bridges fundamental biomechanics with translational engineering, offering a safer, more scalable alternative to conventional injections. Her contributions have been recognized as a paradigm shift in ingestible robotics, positioning her as a key figure in the next generation of non-invasive therapeutic delivery systems.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
Cephalopod-inspired jetting devices for gastrointestinal drug delivery
52 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: Novo Nordisk (Denmark)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago